OTCM
KNWN
Market cap22mUSD
Mar 28, Last price
0.73USD
Name
Know Labs Inc
Chart & Performance
Profile
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||||
Revenues | 4,360 | |||||||||
Cost of revenue | 15,223 | 14,042 | 16,934 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (15,223) | (14,042) | (12,574) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 7,497 | |||||||||
Tax Rate | ||||||||||
NOPAT | (15,223) | (14,042) | (20,071) | |||||||
Net income | (16,582) -18.89% | (20,443) -25.85% | (27,568) 8.71% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 5,193 | 5,473 | 9,145 | |||||||
BB yield | -21.07% | -44.15% | -12.38% | |||||||
Debt | ||||||||||
Debt current | 4,533 | 2,917 | 2,470 | |||||||
Long-term debt | 1,016 | 155 | 390 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | 2,438 | (4,952) | (9,734) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (12,829) | (10,354) | (6,920) | |||||||
CAPEX | (66) | (81) | (855) | |||||||
Cash from investing activities | (66) | (81) | (855) | |||||||
Cash from financing activities | 7,983 | 5,865 | 8,111 | |||||||
FCF | (15,402) | (13,117) | (20,605) | |||||||
Balance | ||||||||||
Cash | 3,111 | 8,024 | 12,594 | |||||||
Long term investments | ||||||||||
Excess cash | 3,111 | 8,024 | 12,376 | |||||||
Stockholders' equity | (138,625) | (121,758) | (101,347) | |||||||
Invested Capital | 141,659 | 128,418 | 113,767 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 86,068 | 49,581 | 40,370 | |||||||
Price | 0.29 14.56% | 0.25 -86.34% | 1.83 -26.51% | |||||||
Market cap | 24,650 98.86% | 12,395 -83.22% | 73,878 1.02% | |||||||
EV | 27,091 | 7,446 | 64,147 | |||||||
EBITDA | (14,953) | (13,586) | (12,253) | |||||||
EV/EBITDA | ||||||||||
Interest | 1,358 | 262 | 8,019 | |||||||
Interest/NOPBT |